Your session is about to expire
← Back to Search
Individualized tDCS for Motor Function Improvement
Study Summary
This trial will test whether a method of individually tailoring transcranial direct current stimulation (tDCS) can help to improve the stimulation's effects on behavior.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of epilepsy or claustrophobia.You have a problem with alcohol or drug abuse.You cannot have any metal in your body.I am a healthy volunteer or had a stroke at least 6 months ago.I am currently receiving treatment for a mental health condition.I have never had epilepsy.You are right-handed.You have metal inside your body.
- Group 1: 4mA stimulation
- Group 2: Sham stimulation
- Group 3: Individualized stimulation
- Group 4: 2mA stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly participants being sought for this clinical research?
"This research study is searching for subjects aged 18 and under 60 years old."
Who meets the requirements to partake in this research?
"30 individuals of legal age and below 60 years old, who have tdcs, are sought for this study. Further requirements for participants include being in good health without any history of brain injury, epilepsy or psychiatric diagnoses; no metal inside the body; and not having any contraindications to TMS or MRI scanning."
Is enrollment still available for this medical trial?
"While listed on clinicaltrials.gov, this medical trial is not in the process of recruiting patients. It was initially announced on April 1st 2022 and modified two months later; however, there are 6 other active trials currently open for enrollment."
Share this study with friends
Copy Link
Messenger